Six Action Steps to Address Global Disparities in Parkinson Disease: A World Health Organization Priority.


Journal

JAMA neurology
ISSN: 2168-6157
Titre abrégé: JAMA Neurol
Pays: United States
ID NLM: 101589536

Informations de publication

Date de publication:
01 09 2022
Historique:
pubmed: 12 7 2022
medline: 15 9 2022
entrez: 11 7 2022
Statut: ppublish

Résumé

The Global Burden of Disease study conducted between 1990 and 2016, based on a global study of 195 countries and territories, identified Parkinson disease (PD) as the fastest growing neurological disorder when measured using death and disability. Most people affected by PD live in low- and middle-income countries (LMICs) and experience large inequalities in access to neurological care and essential medicines. This Special Communication describes 6 actions steps that are urgently needed to address global disparities in PD. The adoption by the 73rd World Health Assembly (WHA) of resolution 73.10 to develop an intersectoral global action plan on epilepsy and other neurological disorders in consultation with member states was the stimulus to coordinate efforts and leverage momentum to advance the agenda of neurological conditions, such as PD. In April 2021, the Brain Health Unit at the World Health Organization convened a multidisciplinary, sex-balanced, international consultation workshop, which identified 6 workable avenues for action within the domains of disease burden; advocacy and awareness; prevention and risk reduction; diagnosis, treatment, and care; caregiver support; and research. The dramatic increase of PD cases in many world regions and the potential costs of PD-associated treatment will need to be addressed to prevent possible health service strain. Across the board, governments, multilateral agencies, donors, public health organizations, and health care professionals constitute potential stakeholders who are urged to make this a priority.

Identifiants

pubmed: 35816299
pii: 2793874
doi: 10.1001/jamaneurol.2022.1783
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

929-936

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Auteurs

Nicoline Schiess (N)

Brain Health Unit, Department of Mental Health and Substance Use, World Health Organization, Geneva, Switzerland.

Rodrigo Cataldi (R)

Brain Health Unit, Department of Mental Health and Substance Use, World Health Organization, Geneva, Switzerland.

Michael S Okun (MS)

Department of Neurology, Norman Fixel Institute for Neurological Diseases, University of Florida, Gainesville.
Associate Editor, JAMA Neurology.

Natasha Fothergill-Misbah (N)

Department of Gerontology, University of Southampton, Southampton, United Kingdom.

E Ray Dorsey (ER)

University of Rochester, Rochester, New York.

Bastiaan R Bloem (BR)

Donders Institute for Brain, Cognition and Behaviour, Department of Neurology, Radboud University Medical Centre, Nijmegen, the Netherlands.

Maria Barretto (M)

Parkinson's Disease and Movement Disorder Society, Mumbai, India.

Roongroj Bhidayasiri (R)

Chulalongkorn Centre of Excellence for Parkinson's Disease and Related Disorders, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand.
The Academy of Science, The Royal Society of Thailand, Bangkok, Thailand.

Richard Brown (R)

Chemical Safety and Health Unit, Department of Environment, Climate Change and Health, World Health Organization, Geneva, Switzerland.

Lorraine Chishimba (L)

University Teaching Hospital, Lusaka, Zambia.

Neerja Chowdhary (N)

Brain Health Unit, Department of Mental Health and Substance Use, World Health Organization, Geneva, Switzerland.

Max Coslov (M)

Edmond J. Safra Foundation, Geneva, Switzerland.

Esther Cubo (E)

Hospital Universitario Burgos, Burgos, Spain.

Alessandro Di Rocco (A)

Zucker School of Medicine at Hofstra Northwell, Uniondale, New York.

Rachel Dolhun (R)

The Michael J. Fox Foundation, New York, New York.

Christopher Dowrick (C)

University of Liverpool, Liverpool, United Kingdom.

Victor S C Fung (VSC)

Movement Disorders Unit, Department of Neurology, Westmead Hospital and University of Sydney, Sydney, Australia.

Oscar S Gershanik (OS)

Institute of Neuroscience, Favaloro Foundation University Hospital, Buenos Aires, Argentina.

Larry Gifford (L)

Person With Parkinsons, PD Avengers, Vancouver, British Columbia, Canada.

Joyce Gordon (J)

Neurological Health Charities Canada, Toronto, Ontario, Canada.

Hanan Khalil (H)

College of Health Sciences, Department of Physiotherapy, Qatar University, Doha, Qatar.

Andrea A Kühn (AA)

Department of Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Sara Lew (S)

Malaysian Parkinson's Disease Association, Kuala Lumpur, Malaysia.

Shen-Yang Lim (SY)

Division of Neurology, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
The Mah Pooi Soo and Tan Chin Nam Centre for Parkinson's and Related Disorders, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.

Maria M Marano (MM)

Parkinson Canada, Toronto, Ontario, Canada.

Jacquie Micallef (J)

Parkinson Canada, Toronto, Ontario, Canada.

Jolynne Mokaya (J)

University of Oxford, Oxford, United Kingdom.

Emile Moukheiber (E)

Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Lynda Nwabuobi (L)

Weill Cornell Parkinson's Disease and Movement Disorders Institute, New York, New York.

Njideka Okubadejo (N)

College of Medicine, University of Lagos, Lagos, Nigeria.

Pramod Kumar Pal (PK)

National Institute of Mental Health and Neurosciences, Bengaluru, India.

Hiral Shah (H)

Columbia University Medical Center, New York, New York.

Ali Shalash (A)

Department of Neurology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

Todd Sherer (T)

The Michael J. Fox Foundation, New York, New York.

Bernadette Siddiqui (B)

The Michael J. Fox Foundation, New York, New York.

Ted Thompson (T)

The Michael J. Fox Foundation, New York, New York.

Andreas Ullrich (A)

Department of Gynaecology and Gynaecological Oncology Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Richard Walker (R)

Northumbria Healthcare NHS Foundation Trust, Newcastle-upon-Tyne, United Kingdom.

Tarun Dua (T)

Brain Health Unit, Department of Mental Health and Substance Use, World Health Organization, Geneva, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH